家庭过夜血氧监测预测阿片类药物患者睡眠呼吸暂停的性能
该研究为前瞻性队列的事后分析,纳入5家疼痛诊所181例长期使用阿片类药物的慢性疼痛患者,对比家庭过夜血氧监测的ODI 4%与多导睡眠监测的AHI。ODI预测中重度睡眠呼吸暂停(AHI≥15)的AUC为0.82,预测重度(AHI≥30)的AUC为0.87,提示家庭血氧监测对此类患者具有较高预测性能。
要点
- 家庭过夜血氧监测ODI 4%预测中重度睡眠呼吸暂停的AUC为0.82。
- ODI≥5次/小时预测中重度睡眠呼吸暂停的敏感性85%、特异性57%。
- 家庭血氧监测可作为阿片类药物患者睡眠呼吸暂停筛查的辅助工具。
核心结论
- 家庭过夜血氧监测在长期使用阿片类药物的慢性疼痛患者中,对中重度和重度睡眠呼吸暂停具有较高预测性能。
研究设计与样本
- 前瞻性队列研究的事后分析,在5家疼痛诊所纳入332例同意患者,其中181例同时具备多导睡眠监测和过夜血氧监测数据。
主要发现
- ODI预测中重度睡眠呼吸暂停(AHI≥15次/小时)的AUC为0.82(95%CI 0.75-0.88)。
- ODI预测重度睡眠呼吸暂停(AHI≥30次/小时)的AUC为0.87(95%CI 0.80-0.94)。
- ODI≥5次/小时预测中重度睡眠呼吸暂停的敏感性85%(95%CI 74-92)、特异性57%(95%CI 52-61)。
- ODI≥15次/小时预测重度睡眠呼吸暂停的敏感性71%(95%CI 55-83)、特异性88%(95%CI 84-91)。
关键数值与推荐
- ODI≥5次/小时用于预测中重度睡眠呼吸暂停(AHI≥15次/小时)。
- ODI≥15次/小时用于预测重度睡眠呼吸暂停(AHI≥30次/小时)。
临床怎么用
- 对长期使用阿片类药物的慢性疼痛患者,可考虑家庭过夜血氧监测作为睡眠呼吸暂停的筛查工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long-term use of opioids for treatment of chronic pain is associated with significant risks including worsening unrecognized or untreated sleep apnea that may increase morbidity and mortality. Overnight oximetry has been validated for predicting sleep apnea in surgical and sleep clinic patients. The objective of the study was to assess the predictive accuracy of oxygen desaturation index (ODI 4%) from home overnight oximetry when compared to apnea hypopnea index (AHI) from polysomnography for predicting sleep apnea in patients taking opioids for chronic pain. METHODS: This was a planned post hoc analysis of a prospective cohort study conducted at 5 pain clinics. Patient characteristics and daily morphine milligram equivalent (MME) dose were recorded. All consented patients underwent home overnight oximetry (PULSOX-300i, Konica Minolta Sensing, Inc, Osaka, Japan) and in-laboratory polysomnography. The predictive performance of ODI 4% from oximetry was assessed against AHI from polysomnography. RESULTS: Among 332 consented patients, 181 with polysomnography and overnight oximetry data were analyzed. The mean age and body mass index of 181 patients were 52 ± 13 years and 29 ± 6 kg/m2, respectively, with 40% men. The area under the receiver operating curve for ODI to predict moderate-to-severe sleep apnea (AHI ≥15 events/h) and severe sleep apnea (AHI ≥30 events/h) was 0.82 (95% confidence interval [CI], 0.75-0.88) and 0.87 (95% CI, 0.80-0.94). ODI ≥5 events/h had a sensitivity of 85% (95% CI, 74-92) and specificity of 57% (95% CI, 52-61) to predict moderate-to-severe sleep apnea. ODI ≥15 events/h had a sensitivity of 71% (95% CI, 55-83) and specificity of 88% (95% CI, 84-91) to predict severe sleep apnea. CONCLUSIONS: Overnight home oximetry has a high predictive performance in predicting moderate-to-severe and severe sleep apnea in patients on opioids for chronic pain. It is a useful additional tool for health care providers for the screening of sleep apnea in this high-risk group.
引用
- Waseem R, Wong J, Ryan C, et al. Predictive Performance of Oximetry to Detect Sleep Apnea in Patients Taking Opioids. Anesth Analg. 2021. PMID: 33950884. doi:10.1213/ANE.0000000000005545
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。